not tagged
nrg oncology
[]
#asco2022 chmura nrg-br002 systemic rx +/- sbrt or surgical resection for newly oligometastatic bc. phase 2r n = 128, then on to phase 3 planned if initial pfs results positive. did not make it to phase 3, with no pfs signal. new mets are the issue. disappointing results.
Professor of Medicine, Stanford University; breast cancer doc